| Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| SLC6A2 |
solute carrier family 6 (neurotransmitter transporter), member 2 |
16q12.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
13(4/9/0)
|
IEA
|
| GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
Literature-origin |
1(0/0/1)
|
IDA[7685113]
|
| SLC22A9 |
solute carrier family 22 (organic anion transporter), member 9 |
11q12.3 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IBA
|
| OPRL1 |
opiate receptor-like 1 |
20q13.33 |
Literature-origin, Mapped by Literature SNP |
0
|
IDA[8137918|12568343]
|
| CLPTM1 |
cleft lip and palate associated transmembrane protein 1 |
19q13.3 |
rSNP target |
0
|
TAS[9828125]
|
| ABCC1 |
ATP binding cassette subfamily C member 1 |
16p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IEA
|
| CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
TAS[1718258]
|
| SLC18A2 |
solute carrier family 18 (vesicular monoamine transporter), member 2 |
10q25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(2/1/0)
|
TAS[8095030]
|
| GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS[8768735]
|
| DRD4 |
dopamine receptor D4 |
11p15.5 |
Literature-origin, Mapped by Literature SNP |
7(2/5/0)
|
IDA[8413587|9843378|15755724]
|
| ADCYAP1R1 |
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
7p14.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
19(8/11/0)
|
TAS[7902709]
|
| TNF |
tumor necrosis factor |
6p21.3 |
Mapped by Literature SNP |
1(1/0/0)
|
IDA[18355445]
|
| VIPR1 |
vasoactive intestinal peptide receptor 1 |
3p22 |
rSNP target |
0
|
TAS[8179610]
|
| ADRB2 |
adrenoceptor beta 2 |
5q31-q32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IDA[12297500]
|
| HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
5q12.3 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
IDA[22957663]
|
| HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(2/2/0)
|
IEA
|
| CRHR1 |
corticotropin releasing hormone receptor 1 |
17q21.31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
12(6/6/0)
|
TAS[10598591]
|
| DRD2 |
dopamine receptor D2 |
11q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
18(11/7/0)
|
IC[2531656]; IDA[8413587]
|
| DRD3 |
dopamine receptor D3 |
3q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(1/1/0)
|
IC[8301582]; IDA[8413587]
|
| SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(11/10/0)
|
IBA
|
| CHRNB4 |
cholinergic receptor, nicotinic beta 4 |
15q24 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
IC[11742001]
|
| SLC20A2 |
solute carrier family 20 (phosphate transporter), member 2 |
8p11.21 |
rSNP target |
0
|
TAS[8302848]
|
| TSPAN1 |
tetraspanin 1 |
1p33 |
rSNP target |
0
|
IBA
|
| SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
44(13/31/0)
|
IBA; IC[19270731]
|
| FASLG |
Fas ligand |
1q23 |
Literature-origin |
1(0/0/1)
|
TAS[7826947]
|
| NLGN1 |
neuroligin 1 |
3q26.32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IBA; ISS
|
| TRPA1 |
transient receptor potential cation channel, subfamily A, member 1 |
8q13 |
rSNP target |
0
|
IMP[20547126|25855297]
|
| LGR6 |
leucine-rich repeat containing G protein-coupled receptor 6 |
1q32.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
ISS
|
| CAPRIN1 |
cell cycle associated protein 1 |
11p13 |
rSNP target |
0
|
TAS[7657653]
|
| TRHDE |
thyrotropin-releasing hormone degrading enzyme |
12q21.1 |
Mapped by LD-proxy |
0
|
TAS[10491199]
|
| GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IDA[9872316]
|
| OXTR |
oxytocin receptor |
3p25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
TAS[10858434]
|
| GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS[8768735]
|
| NRXN3 |
neurexin 3 |
14q31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS[1621094]
|
| PLXNC1 |
plexin C1 |
12q23 |
Literature-origin |
1(0/0/1)
|
IBA
|
| CRHR2 |
corticotropin releasing hormone receptor 2 |
7p14.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(2/0/0)
|
TAS[8536644]
|
Basic Info
